Literature DB >> 3323264

Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.

P Blier1, C de Montigny, Y Chaput.   

Abstract

Results of electrophysiological single-cell recording studies suggest that most, if not all, types of antidepressant treatments increase 5-hydroxytryptamine (5-HT) neurotransmission. Tricyclic antidepressants, electroconvulsive shock treatment, mianserin, adinazolam, and possibly sleep deprivation may exert their therapeutic effect through sensitization of postsynaptic neurons to 5-HT. Serotonin reuptake blockers may relieve depression through an increased efficacy of the presynaptic element resulting from a desensitization of somatodendritic and terminal 5-HT autoreceptors. Similarly, monoamine oxidase inhibitors may act by increasing the efficacy of 5-HT neurons. Intensification of 5-HT function appears to be a common denominator to antidepressant treatments; however, evidence suggests that this modification may only be a link in a chain of events leading to an antidepressant response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323264

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  66 in total

Review 1.  Toward an integrative understanding of social phobia.

Authors:  D Li; P Chokka; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging.

Authors:  Sakthivel Sekar; M Verhoye; J Van Audekerke; G Vanhoutte; Andrew S Lowe; Andrew M Blamire; Thomas Steckler; A Van der Linden; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2010-11-20       Impact factor: 4.530

Review 3.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

4.  Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.

Authors:  A Woods; C Smith; M Szewczak; R W Dunn; M Cornfeldt; R Corbett
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  An extract of Synedrella nodiflora (L) Gaertn exhibits antidepressant properties through monoaminergic mechanisms.

Authors:  Patrick Amoateng; Kennedy Kwami Edem Kukuia; Jeffrey Amoako Mensah; Dorcas Osei-Safo; Samuel Adjei; Audrey Akyea Eklemet; Emmanuel Atsu Vinyo; Thomas K Karikari
Journal:  Metab Brain Dis       Date:  2018-05-12       Impact factor: 3.584

6.  Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.

Authors:  P Celada; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

Review 7.  Future antidepressants: what is in the pipeline and what is missing?

Authors:  Fokko J Bosker; Ben H C Westerink; Thomas I F H Cremers; Marjolein Gerrits; Marieke G C van der Hart; Sjoukje D Kuipers; Gieta van der Pompe; Gert J ter Horst; Johan A den Boer; Jakob Korf
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

8.  Fluoxetine augments ventilatory CO2 sensitivity in Brown Norway but not Sprague Dawley rats.

Authors:  Matthew R Hodges; Ashley E Echert; Madeleine M Puissant; Gary C Mouradian
Journal:  Respir Physiol Neurobiol       Date:  2013-02-27       Impact factor: 1.931

9.  The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects.

Authors:  H S Driver; M J Flanigan; A J Bentley; H G Luus; C M Shapiro; D Mitchell
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

Review 10.  Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.

Authors:  M V Rudorfer; W Z Potter
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.